Brachiocephalic vein thrombosis associated with Crohn's disease

Journal of Gastroenterology

Volumn 38, Issue 3, 2003, Pages 268-271

  Ribeiro, João M ^a   Rebocho, Luísa ^a   Lucas, Margarida B ^a   Campos, Paula ^a   Victorino, Rui M M ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Coagulation disorders; Crohn's disease; Inflammatory bowel disease; Macrovascular thrombosis; Thrombosis

Indexed keywords

MESALAZINE; METRONIDAZOLE; PLASMINOGEN ACTIVATOR INHIBITOR; PREDNISONE; WARFARIN;

ADULT; ARM EDEMA; ARTICLE; BRACHIOCEPHALIC VEIN; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; ENTERITIS; FACE EDEMA; FEMALE; FIBRINOLYSIS; HEMATOCHEZIA; HUMAN; ILEUM RESECTION; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MALABSORPTION; PATHOGENESIS; PRIORITY JOURNAL; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; BRACHIOCEPHALIC VEINS; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; VENOUS THROMBOSIS; WARFARIN;

EID: 0038071757     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350300046     Document Type: Article

References (16)

1. Sidorov JJ. The protean complications of inflammatory bowel disease. In: de Dombal FT, Myren J, Bouchier IAD, Watkinson G, Softley A, editors. Inflammatory bowel disease. 2nd ed. New York: Oxford University Press; 1993. p. 204-323.
2. Talbot RW, Heppell J, Dozois RR, Beart RW. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61: 140-5.
3. Jackson LM, O'Gorman PJ, Connell J, Cronin CC, Cotter KP, Shanahan F. Thrombosis in Inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. Q J Med 1997; 90:183-8.
4. Wakefield AJ, Dhillon AP, Rowels PM, Sawyerr AM, Pittilo RM, Lewis AM. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;II:1057-62.
5. Conlan MG, Haire WD, Burnett DA. Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci 1989;34:1089-93.
6. Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzalez D, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995;40:1883-9.
7. Martinelli I, Cattaneo M, Panzeri D, Taioli E, Mannucci PM. Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med 1997;126:707-11.
8. Schafer AI. Hyppercoagulable states: molecular genetics to clinical practice. Lancet 1994;344:1739-42
9. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000;342:1792-801.
10. Sawyerr AM, Smith MS, Hall A, Hudson M, Hay CR, Wakefield AJ, et al. Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases. Dig Dis Sci 1995;40:793-9.
11. Novacek G, Vogelsang H, Genser D, Moser G, Gangl A, Ehringer H, et al. Changes in blood rheology by Crohn's disease. Eur J Gastroenterol Hepatol 1996;81:1089-93.
12. Smith CJ, Haire WD, Kaufman SS, Mack DR. Determination of prothrombin fragments in young patients with inflammatory bowel disease. Am J Gastroenterol 1996;91:1221-5.
13. Chamouard P, Grunebaum L, Wiesel ML, Freyssinet JM, Duclos B, Cazenave JP, et al. Prevalence and significance of cardiolipin antibodies in Crohn's disease. Dig Dis Sci 1994;39:1501-4.
14. Vainer B. Role of cell adhesion molecules in inflammatory bowel disease. Scand J Gastroenterol 1997;32:401-10.
15. Jones SC, Banks RE, Haidar A. Adhesion molecules in inflammatory bowel disease. Gut 1995;36:724-30.
16. Wallace JL, Beck PL. Inflammatory mediators in IBD. Curr Opin Gastroenterol 1996;12:334-9.